HSCS - HeartSciences • Financials

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
04/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
04/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
04/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
04/2023	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
04/2024	0	-6	-	L	L	7	L	-5	-	-6	-0	10	-7	0	0	-	-
04/2025	0	-8	-	L	L	0	L	1	L	-8	-0	3	-8	0	0	-	-
04/2026	0	-8	-	L	L	0	L	2	L	-9	-0	8	-9	0	0	-	-

To see all financials—including updated, you must be Premium.